Stryker Corporation CEO Unveils Innovation Strategy; Calls for More Collaboration, Clinical Evidence & Global Growth

Published: Oct 30, 2012

Just one month ago, Kevin Lobo took over the top spot at medical device maker Stryker Corp. (NYSE:SYK) On Monday, he explained the $8.5 billion corporation’s innovation strategy moving forward in his first public appearance as CEO at Cleveland Clinic’s Medical Innovation Summit.

Formerly president of J&J company Ethicon Endo-Surgery and then head of Stryker’s orthopedics unit, Lobo replaced CFO Curt Hartman, who served as interim CEO following the resignation of Stephen MacMillen in February.

Back to news